Control of uterine activity and prevention of premature birth.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003981:Diazoxide / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D007556:Isoxsuprine / Q000031:analogs & derivatives / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010627:Phenethylamines / Q000627:therapeutic use; D010636:Phenols / Q000627:therapeutic use; D010902:Pituitary Gland / Q000187:drug effects; D011247:Pregnancy; D011412:Propanolamines / Q000627:therapeutic use; D011448:Prostaglandin Antagonists; D011941:Receptors, Adrenergic; D014599:Uterus / Q000187:drug effects / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D010627:Phenethylamines; D010636:Phenols; D011412:Propanolamines; D011448:Prostaglandin Antagonists; D011941:Receptors, Adrenergic; D000431:Ethanol; D010121:Oxytocin; D009921:Metaproterenol; D007545:Isoproterenol; D003981:Diazoxide; D007556:Isoxsuprine; D001241:Aspirin; D009638:Norepinephrine; D004837:Epinephrine